Efonidipine-Induced Exanthematic Drug Eruption and Literature Review

J Cardiovasc Pharmacol. 2019 Jun;73(6):394-396. doi: 10.1097/FJC.0000000000000676.

Abstract

We report the case of an elderly woman who developed exanthematic drug eruption after administration of efonidipine. An 84-year-old woman presented to emergency department with complaints of generalized itching and erythema since 4 days. She was on human-soluble insulin since 11 years. In view of her hypertension and left anterior descending artery stenosis, she was initiated on aspirin, clopidogrel, atorvastatin, pantoprazole, nebivolol, aldactone, and efonidipine a week ago. Her presenting complaints were initially managed with parenteral pheniramine maleate and hydrocortisone. She was admitted, and all her medications except antiplatelets and insulin were discontinued. She was prescribed topical beclomethasone and oral antihistamines for better control of her symptoms. To confirm the drug precipitating the reaction, she was rechallenged with efonidipine, 20 mg once daily on the third day of admission. She developed itching 8 hours after administering the medication, and efonidipine was stopped and nebivolol 5 mg once daily was restarted for hypertension. She did not develop any adverse event when the remaining medications were reinitiated. World Health Organization-Uppsala Monitoring Centre causality assessment criteria indicated a "certain" association. To the best of the knowledge of the authors, this is one among the first reported cases of efonidipine-induced exanthematic drug eruption.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Aged, 80 and over
  • Calcium Channel Blockers / adverse effects*
  • Dihydropyridines / adverse effects*
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Exanthema / chemically induced*
  • Exanthema / drug therapy
  • Exanthema / pathology
  • Female
  • Glucocorticoids / administration & dosage
  • Histamine Antagonists / administration & dosage
  • Humans
  • Nitrophenols / adverse effects*
  • Organophosphorus Compounds / adverse effects
  • Skin / drug effects*
  • Skin / pathology
  • Treatment Outcome

Substances

  • Calcium Channel Blockers
  • Dihydropyridines
  • Glucocorticoids
  • Histamine Antagonists
  • Nitrophenols
  • Organophosphorus Compounds
  • efonidipine